Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics | $28.37 | $22.01 | 346.07% | 52.7M | $290.8M | $4.30$40.37 |
| IRBT | iRobot | $3.27 | $1.32 | 67.44% | 205.4M | $62.1M | $1.40$13.06 |
| KXIN | Kaixin | $4.08 | $0.98 | 31.61% | 13.6M | $84.5M | $2.94$75.00 |
| MPLT | MapLight Therapeutics | $16.80 | $3.91 | 30.29% | 717.9K | $534.0M | $12.24$20.86 |
| AHMA | Ambitions Enterprise Management L.l.c | $15.80 | $3.55 | 28.98% | 5.9M | $361.4M | $4.00$18.20 |
| PMAX | Powell Max | $2.91 | $0.64 | 28.19% | 21.5M | $6.6M | $1.56$25.44 |
| AARD | Aardvark Therapeutics | $11.80 | $2.54 | 27.43% | 455.8K | $201.6M | $4.88$19.58 |
| BCTX | BriaCell Therapeutics | $12.70 | $2.70 | 27.02% | 154.2K | $18.8M | $6.00$190.50 |
| POET | Poet Technologies | $5.94 | $1.26 | 26.92% | 480.9K | $424.6M | $3.09$9.41 |
| NNNN | Anbio Biotechnology | $35.00 | $7.30 | 26.35% | 56.1K | $1.2B | $5.00$55.65 |
Related Articles
Featured Article
Better Robotics Stock: Richtech Robotics vs. Serve Robotics
George Budwell, PhD|Nov 17, 2025
These two robotics companies sport similar market caps but radically different business models.
5 Emerging Tech Stocks I'm Buying on This Sharp Pullback
George Budwell, PhD|Nov 15, 2025
The recent sell-off is an opportunity for long-term investors.
8 AI Stocks I'd Buy Right Now
George Budwell, PhD|Nov 13, 2025
From proven megacaps to speculative small caps, these eight stocks span the AI infrastructure stack at different risk levels.
Why Poet Technologies Stock Soared 16.2% in October
Scott Levine|Nov 9, 2025
This pure-play AI stock caught investors' attention last month for a couple of different reasons.
Is Richtech Robotics Stock a Buy?
George Budwell, PhD|Oct 11, 2025
This robotics upstart has surged 143% year to date, but early-stage revenue and a high price tag raise questions about the artificial intelligence (AI) automation story.
Is Poet Technologies Stock a Buy?
George Budwell, PhD|Oct 9, 2025
A $75 million capital raise and partnerships with industry giants are fueling optimism, but revenue remains minimal.
iRobot Is a Falling Knife That's Too Risky for Most
Joseph Arroyo|Jul 23, 2024
iRobot's faces a looming cash-flow crunch.
With Its New CEO On Board, Is It Time to Reassess Investing in This Household Robot Maker?
Nicholas Robbins|Jul 4, 2024
Learn how iRobot's ongoing strategic moves and a new CEO might make it a smart investment choice in the evolving home robotics market.
iRobot Has a New CEO, and There's a Lot of Work to Do
Reuben Gregg Brewer|Jul 3, 2024
The new leader of iRobot has more than usual on his plate because the company is stuck in turnaround mode.
Can iRobot Stock Bounce Back After Crashing 72% This Year?
David Jagielski, CPA|May 25, 2024
Turnaround plays are risky options, although they do possess a lot of potential upside if they go well.
